Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-02-07
2006-02-07
Chang, Celia (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S212000, C546S214000, C546S216000, C546S223000, C546S229000, C546S232000, C514S317000, C514S318000, C514S327000, C514S328000, C514S331000
Reexamination Certificate
active
06995268
ABSTRACT:
N- and O-substituted 4[2-diaromaticmethoxy and methylamino)alkyl]piperidines exhibit high CNS activity with respect to the dopamine transporter (DAT) and serotonin transporter (SERT). Preferred compounds exhibit highly differential behavior as between the DAT and SERT and between the DAT and the norepinephrine transporter (NET). The compounds have utility in treating CNS disorders, including but not limited to cocaine addiction, depression, and Parkinson's disease.
REFERENCES:
patent: 5232929 (1993-08-01), DeSai et al.
patent: 5300499 (1994-04-01), Chow
patent: 5344835 (1994-09-01), Alker et al.
patent: 0 217 286 (1987-04-01), None
patent: 0 417 698 (1991-03-01), None
patent: WO 98 50534 (1998-11-01), None
patent: WO 99 25686 (1998-11-01), None
Baker Botts “In Prints-reach through claims” Attorneys practice profiles news & events (2002).
Burger “Medicinal Chemistry” p. 25 (1970).
Rubini et al. “Synthesis of isosteric methylene-oxy . . . ” Tetrahedron v.42(21) 6039-45 (1986).
M.J. Kuhar, “Neurotransmitter Uptake: A Tool in Identifying Neurotransmitter Specific Pathways,” Life Sci., 13, 1623-34, 1973.
M.E.A. Reith et al., “Strucural Requirements for Cocaine Congeners to Interact with Dopamine and Serotonin Uptake Sites in Mouse Brain and to Induced Stereotyped Behavior,” Biochem. Pharmacol., 1986, 35, 1123-1129.
M.C. Ritz et al., “Cocaine Inhibition of Ligand Binding at Dopamine, Norpinephrine and Serotonin Transporters: A Structure-Activity Study,” Life. Sci., 1990, 46, 635-645.
M.C. Ritz et al., “Cocaine Receptors on Dopamine Transporters are Related to Self-Administration of Cocaine,” Science, 1987, 237, 1219-1223.
B. Giros et al., “Hyperlocomotion and Indifference to Cocaine and Amphetamine in Mice Lacking the Dopamine Transporter,” Nature, 1996, 379, 606-612.
H. Shoemaker et al., Naunyn Schmiedebergs Arch. Pharmacol., 1985, 329, 227-235.
J.M. Maloteaux et al., Eur. J. Pharm., 1988, 156, 331-340.
H.B. Niznik et al., Arch. Biochem. Biophys., 1990, 276, 424-432.
K.M. Johnson, “Phencyclidine: Behavioral and Biochemical Evidence Supporting a Role for Dopamine,” Fed. Proc., 1983, 42, 2579-3583.
E.D. French et al., “Phencyclidine Binding Sites in the Nucleus Accumbens and Phencyclidine-Induced Hyperactivity are Decreased Following Legions of the Mesolimbic Dopamine System,” Eur. J. Pharmacol., 1985, 116, 1-9.
J. Langston et al., “MPTP: Current Concepts and Controversies,” Clin. Neuropharmac., 1986, 9, 485-507.
H. Kinemuchi et al., “The Neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its Relevance to Parkinson's Disease,” Neurochem. Int., 1987, 11, 359-373.
F.I. Carroll et al., “Cocaine Receptor: Biochemical Characterization and Structure-Activity Relationship of Cocaine Analogues at the Dopamine Transporter,” J. Med. Chem., 1992, 35, 969-981.
R.A. Millius et al., “Synthesis and Receptor Binding of N-substituted Tropane Derivatives,” “High Affinity Ligands for Cocaine Receptor,” J. Med. Chem., 1991, 34, 1728-1731.
I. Chaudieu et al., “Role of the Aromatic Group in the Inhibition of Phencyclidine Binding and Dopamine Uptake by PCP Analogs,” Pharmacol. Biochem. Behav., 1989, 32, 699-705.
J. Vignon et al., “[3H]N-[1(2-Benzo(b)thienyl)cyclohexyl]piperidine([3H]BTCP): A New Phencyclidine Analog Selective for the Dopamine Uptake Complex,” Eur. J. Pharmacol., 1988, 148, 427-436.
P.H. Anderson, “Biochemical and Pharmacological Characterization of [3H]GBR 12935 Binding in Vitro to Rat Striatal Membranes: Labeling of the Dopamine Uptake Complex,” J. Neurochem., 1987, 48, 1887-1896.
P.H. Anderson, “The Dopamine Uptake Inhibitor GBR 12909: Selectivity and Molecular Mechanism of Action,” Eur. J. Pharmacol., 1989, 166, 493-504.
R.B. Kolhatkar et al., “Interaction of cis-(6-Benzhydrylpiperidin-3-y)benzylamine Analogues with Monoamine Transporters: Structure-Activity Relationship Study of Structurally Constrained 3,6-Disubstituted Piperidine Analogues of (2,2-Diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine,” J. Med. Chem. 2003, 46, 2205-2215.
C. DeVries et al., “Heteroaromatic Analogs of 1-2[2-(diphenylmethoxy(ethyl]- and 1-[2[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as High-Affinity Dopamine Reuptake Inhibitors,” J. Med. Chem., 1997, 40, 705-716.
D. Matecka et al., Development of Novel, Potent, and Selective Dopamine Reuptake Inhibitors Through Alteration of the Piperazine Ring of 1-[2-(diphenylmethoxy)ethyl]- and 1[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909), J. Med. Chem., 1996, 39, 4704-4716.
R.B. Rothman, “Tight Binding Dopamine Reuptake Inhibitors as Cocaine Antagonists,” FEBS Lett., 1989, 257, 341-344.
U. Sogaard et al., “A Tolerance Study of Single and Multiple Dosing of the Selective Dopamine Uptake Inhibitor GBR 12909 in Healthy Subjects,” Int. Clin. Psychopharm., 1990, 5, 237-251.
J.R. Glowa et al., “The Effects of GBR 12909 on Responding of Rhesus Monkeys Maintained Under Schedules of Cocaine- and Food-Delivery,” NIDA. Res. Monogr., 1994, 141, 12.
A.K. Dutta et al., “Positional Importance of the Nitrogen Atom in Novel Piperidine Analogs of GBR 12909: Affinity and Selectivity for the Dopamine Transporter,” Med. Chem. Res., 1993, 3, 209-222.
A.K. Dutta et al., “Structure-Activity Relationship Studies of Novel 4[2-[Bis(4-fluorophenyl)methoxy]ethy]-1-(3-phenylpropyl)piperidine Analogs: Synthesis and Biological Evaluation of the Dopamine and Serotonin Transporter Sites,” J. Med. Chem., 1996, 39, 749-756.
A.K. Dutta et al., “Highly Selective, Novel Analogs of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine for the Dopamine Transporter: Effect of Different Aromatic Substitutions on their Affinity and Selectivity,” J. Med. Chem., 1997, 40, 35-43.
A.K. Dutta et al., “Potent and Selective Ligands for the Dopamine Transporter (DATE): Structure-Activity Relationship Studies of Novel 4-[2-(diphenylmethoxy)ethyl]-1-(3-phenylpropyl)piperidine Analogs,” J. Med. Chem., 1998, 41, 699-756.
M. Khalid et al., “N,N′-disubstituted L-isoglutamines as Novel Cancer Chemotherapeutic Agent,” Drugs Exp. Clin. Res. (1987), 13 (Suppl. 1), 57-60; ISSN: 0378-6501, 1987.
Database WPI Section Ch., Week 9804, Derwent Publications Ltd., London, GB; Class B03, AN 98-035793 XP002094912 & JP 09 249566 A (Takeda Chem. Ind. Ltd.) Sep. 22, 1997 (see abstract).
Derwent Abstract, Eur. J. Nucl. Med., (1999), 26(4), 342-347, “In Vivo Imaging of Serotonin Transporters with [99mTc]TRODAT-1 in Nonhuman Primates” [AN 1999:196775].
A.K. Dutta et al., “Tolerance in the Replacement of the Benzhydrylic O Atom in 4-[2-(Diphenylmethoxy)ethyl]-1-benzylpiperidine Derivatives by an N Atom: Development of New-Generation Potent and Selective N-Analogue Molecules for the Dopamine Transporter,” J. Med. Chem., vol. 41, No. 17, pp. 3293-3297.
Database on STN Casdata (Columbus, Ohio, USA) Abstract No. 132:119356, Hoepping et al., “Synthesis and biological evaluation of two novel DAT binding technetium complexes” Bioorg. Med. Chem. Lett. (1999) vol. 9, No. 22, pp. 3211-3216.
F. Ivy Carroll et al., “Cocaine and 3β-(4′-Substituted phenyl)tropane-2β-carboxylic Acid Ester and Amide Analogues. New High-Affinity and Selective Compounds for the Dopamine Transporter,” J. Med. Chem. 1995, 38, 379-388.
Brooks & Kushman P.C.
Chang Celia
Wayne State University
LandOfFree
N- and O-substituted 4-[2-(diphenylmethoxy)-ethyl]-1-... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N- and O-substituted 4-[2-(diphenylmethoxy)-ethyl]-1-..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N- and O-substituted 4-[2-(diphenylmethoxy)-ethyl]-1-... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3691102